Fund briefs

CHL nears $100M for fund IIICHL Medical Partners, an investor in early stage life science companies, has raised $94 million for its third fund, according to a regulatory filing. The fund is targeted at $200 million.

The Stamford, Conn.-based firm raised $160 million for fund II in 2002. While the firm’s partners pitch LPs to commit to fund III, they are no doubt talking up such investments as GeneOhm Sciences, a San Diego-based developer of a chip-based diagnostic tool. In February, Becton Dickinson & Co. paid $230 million to acquire GeneOhm, which raised about $40 million from CHL and other investors.

Also in CHL’s portfolio is Spine Wave Inc., a Shelton, Conn.-based company that has raised $90 million as it develops vertebrae fusion technologies.

Greenhill raises $102M for first VC fundGreenhill & Co. Inc., a New York-based investment bank, has raised $102 million for its inaugural VC fund. Greenhill SAVP will invest in early stage tech deals. Managing Directors Steve Brotman and Brian Hirsch, who have recently joined the firm, will manage the VC fund.

A variety of LPs invested in the fund. In addition, Greenhill committed $11 million and the firm’s staff committed about $22 million.

Cross Creek paddles toward $111MCross Creek Capital has launched fund-raising efforts to secure $111 million for its inaugural fund. The Salt Lake City, Utah-based firm is affiliated with Wasatch Advisors. The firm plans to invest in late stage venture deals.

Actis raises $130M for Southeast AsiaActis has raised $70 million in new LP commitments for a mid-market private equity fund focused on opportunities in Southeast Asia. The capital has been added to an initial $60 million that was committed in 2004 when the fund was slated to focus exclusively on Malaysia, for a fund total of $130 million.

Investors in the fund include private sector institutional investors from North America, Europe and Asia. Actis says that due to investor interest, it increased the fund size and turned the Malaysia-focused fund into a fund that will invest across the Asian region. Specifically, the fund will focus on Malaysia, Indonesia, the Philippines and Thailand. —Alastair Goldfisher